Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(186)
•••
Comment by robertshawon Aug 02, 2019 10:53am
58 Views
Post# 29988281

RE:RE:RE:RE:RE:RE:Possible takeover in play

RE:RE:RE:RE:RE:RE:Possible takeover in play
Bunge wrote:
skier59 wrote: I agree 100% with this statement. Lazy Fluckin Idiots could of done a hell of alot better if it was planned out properly. Unfortunately these Clowns don't know how to run a public business, in other words looking out for the best interest of Shareholders. Not sure why you are all running to buy, but go ahead, this will be dead money for quite some time and stuck like mud in the 30's. The SP was well supported around 50 cents for a long time, so there is absolutely no way a PP should of been anywhere below 40 cents. This management team have just shown the market they are wimps and can be taken advantage of anytime in the future. Really sad because the science is great, but management suck really bad ! Can't believe I'm down $40,000 in 1 month.....and no relief in site with this PP now in play. 







A whole bunch of shameless prostitutes run a great business, how could it possible?
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities